Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
Oncology Today with Dr Neil Love
00:00
Management of high-risk del(17p) patients
Tam recommends potent BTKi like zanubrutinib and discusses trade-offs between continuous and fixed-duration therapy for del(17p).
Play episode from 24:02
Transcript
